BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 35716036)

  • 1. Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes.
    Zhou Y; Wang P; Chen XY; Yan BX; Landeck L; Wang ZY; Xu F; Zheng M; Man XY
    Cell Prolif; 2022 Oct; 55(10):e13290. PubMed ID: 35716036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.
    Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J
    Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin.
    Hau CS; Kanda N; Noda S; Tatsuta A; Kamata M; Shibata S; Asano Y; Sato S; Watanabe S; Tada Y
    Am J Pathol; 2013 May; 182(5):1705-17. PubMed ID: 23499548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte proline-rich protein modulates immune and epidermal response in imiquimod-induced psoriatic skin inflammation.
    Matsuno A; Sumida H; Nakanishi H; Ikeyama Y; Ishii T; Omori I; Saito H; Iwasawa O; Sugimori A; Yoshizaki A; Katoh H; Ishikawa S; Sato S
    Exp Dermatol; 2023 Dec; 32(12):2121-2130. PubMed ID: 37926955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Compound K Reduces Psoriasis-related Inflammation by Activation of the Glucocorticoid Receptor in Keratinocytes.
    Wang W; Xu X; Yang M; Jiang M; Wang D; Tang C; Wei W; Chen J
    Curr Mol Pharmacol; 2024 Feb; 17():e18761429254358. PubMed ID: 38389423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes.
    Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R
    Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
    Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
    Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
    Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
    Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model.
    Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L
    Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.
    Peric M; Koglin S; Kim SM; Morizane S; Besch R; Prinz JC; Ruzicka T; Gallo RL; Schauber J
    J Immunol; 2008 Dec; 181(12):8504-12. PubMed ID: 19050268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
    Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
    Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes.
    Li N; Yamasaki K; Saito R; Fukushi-Takahashi S; Shimada-Omori R; Asano M; Aiba S
    J Immunol; 2014 Nov; 193(10):5140-8. PubMed ID: 25305315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside.
    Zhan ZY; Jiang M; Zhang ZH; An YM; Wang XY; Wu YL; Nan JX; Lian LH
    Phytomedicine; 2024 Aug; 131():155783. PubMed ID: 38838402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-κB signalling activation in keratinocytes.
    Meng Q; Liu Y; Yao L; Ma Z; Guo L; Hu T; Luo Y; Chen J; Dang E; Li Z
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):145-156. PubMed ID: 37669859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The STING antagonist H-151 ameliorates psoriasis via suppression of STING/NF-κB-mediated inflammation.
    Pan Y; You Y; Sun L; Sui Q; Liu L; Yuan H; Chen C; Liu J; Wen X; Dai L; Sun H
    Br J Pharmacol; 2021 Dec; 178(24):4907-4922. PubMed ID: 34460100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol extract of Herpetospermum caudigerum Wall ameliorates psoriasis-like skin inflammation and promotes degradation of keratinocyte-derived ICAM-1 and CXCL9.
    Zhong Y; Zhang BW; Li JT; Zeng X; Pei JX; Zhang YM; Yang YX; Li FL; Deng Y; Zhao Q
    J Integr Med; 2023 Nov; 21(6):584-592. PubMed ID: 37989697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.